tiprankstipranks
Advertisement
Advertisement
Tandem Diabetes initiated with a Hold at Deutsche Bank
PremiumThe FlyTandem Diabetes initiated with a Hold at Deutsche Bank
1M ago
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
Premium
Ratings
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
2M ago
Tandem Diabetes receives CE Mark for expanded indications of AID systems
Premium
The Fly
Tandem Diabetes receives CE Mark for expanded indications of AID systems
2M ago
Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs
PremiumThe FlyTandem Diabetes price target lowered to $21 from $24 at Goldman Sachs
2M ago
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
Premium
Company Announcements
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
2M ago
Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook
Premium
Company Announcements
Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook
3M ago
Tandem Diabetes initiated with a Hold at Benchmark
PremiumThe FlyTandem Diabetes initiated with a Hold at Benchmark
3M ago
Tandem Diabetes price target lowered to $55 from $56 at Barclays
Premium
The Fly
Tandem Diabetes price target lowered to $55 from $56 at Barclays
3M ago
Tandem Diabetes Care Charts Growth Amid Transition
Premium
Company Announcements
Tandem Diabetes Care Charts Growth Amid Transition
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100